menu toggle

Webinar Part 1: Leveraging AI within eBV to speed access to therapy

By Myra Reinhardt, Shanna Barnes

Explore the best combination of tech + human expertise

What approach to electronic benefit verification (eBV) is the right solution for now and into the future? eBV technology has changed. While logic-based approaches still have their place, AI has opened up a path to improved access for patients and added benefits for all stakeholders. For manufacturers, working with a patient service provider that blends compassionate human expertise with technology-based resources offers the best chance of optimizing speed to therapy in the increasingly complex and collaborative pharma ecosystem.

Hear from Lash Group’s Myra Reinhardt, VP, Product Innovation and Analytics, and Shanna Barnes, VP, New Business Development, as they share their extensive knowledge of access solutions and patient support.

In Part 1 of this two-part series, you’ll:

  • Gain information on the technology and approach that help accelerates speed to therapy
  • Identify drivers that impact eBV effectiveness 

*Q&A is not included in the on demand recording.

Screen Shot 20200430 at 52008 PM

About The Authors

Myra Reinhardt
Vice President, Product Innovation
Biopharma Services
View Bio
Shanna Barnes
Vice President, Business Development
Lash Group
View Bio